HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung Hyun Kim Selected Research

Erythropoietin

10/2014Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility.
6/2014Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
9/2010The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung Hyun Kim Research Topics

Disease

34Neoplasms (Cancer)
02/2024 - 10/2002
30Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2024 - 07/2005
17Alzheimer Disease (Alzheimer's Disease)
11/2023 - 07/2005
16Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 07/2005
14Leukemia
10/2020 - 10/2002
11Inflammation (Inflammations)
08/2021 - 09/2004
11Ischemic Stroke
09/2018 - 09/2004
9Disease Progression
02/2024 - 03/2006
8Sarcoma (Soft Tissue Sarcoma)
01/2024 - 01/2019
8Infections
03/2023 - 03/2014
7Postoperative Nausea and Vomiting (PONV)
04/2024 - 01/2018
7Pain (Aches)
04/2024 - 05/2017
5Postoperative Pain
04/2024 - 05/2017
5Stroke (Strokes)
02/2023 - 01/2006
5Asthma (Bronchial Asthma)
01/2021 - 04/2011
5Neoplasm Metastasis (Metastasis)
06/2017 - 11/2009
5Osteosarcoma (Osteogenic Sarcoma)
06/2017 - 09/2014
5Body Weight (Weight, Body)
11/2012 - 07/2003
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2009 - 12/2007
4Frontotemporal Dementia (Semantic Dementia)
02/2024 - 05/2014
4Hypotension (Low Blood Pressure)
01/2023 - 01/2014
4Infarction (Infarctions)
09/2018 - 09/2004
4Hypoxia (Hypoxemia)
01/2018 - 08/2003
4Acute Promyelocytic Leukemia
03/2014 - 10/2006
4Amnesia (Dissociative Amnesia)
11/2012 - 07/2003
4Hypersensitivity (Allergy)
08/2012 - 08/2005
4Myeloid Leukemia (Leukemia, Myelocytic)
02/2008 - 10/2002
3Aggressive Fibromatosis (Desmoid)
02/2024 - 10/2022
3Dementia (Dementias)
01/2023 - 03/2019
3Neuroinflammatory Diseases
01/2022 - 09/2018
3Breast Neoplasms (Breast Cancer)
12/2021 - 11/2009
3Atopic Dermatitis (Atopic Eczema)
08/2021 - 11/2017
3Demyelinating Diseases (Demyelinating Disease)
01/2021 - 11/2016
3Wounds and Injuries (Trauma)
07/2014 - 09/2011
3Parkinson Disease (Parkinson's Disease)
11/2009 - 05/2008
3Thymoma (Thymic Carcinoma)
10/2008 - 03/2006
2Globoid Cell Leukodystrophy (Krabbe Disease)
03/2024 - 11/2016
2Deglutition Disorders (Dysphagia)
01/2024 - 01/2014
2Dyslipidemias (Dyslipidemia)
02/2023 - 01/2014
2Motor Neuron Disease (Primary Lateral Sclerosis)
02/2023 - 11/2020
2Gout
02/2023 - 01/2023
2Hypertension (High Blood Pressure)
02/2023 - 08/2022
2Melanoma (Melanoma, Malignant)
01/2023 - 04/2019
2Unconsciousness (Loss of Consciousness)
01/2023 - 04/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2003
10Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2014
9Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2014 - 10/2002
8Neuroprotective AgentsIBA
09/2018 - 03/2006
7Amyloid (Amyloid Fibrils)IBA
11/2023 - 12/2010
6DNA (Deoxyribonucleic Acid)IBA
04/2023 - 08/2003
6Glycogen Synthase (Synthase I)IBA
01/2017 - 09/2004
5Antiviral Agents (Antivirals)IBA
03/2023 - 02/2015
5AllergensIBA
01/2021 - 08/2005
5Scopolamine (Hyoscine)FDA Link
11/2012 - 07/2003
4Analgesics (Analgesic Drugs)IBA
04/2024 - 05/2017
4pazopanibFDA Link
01/2024 - 01/2019
4AntioxidantsIBA
08/2022 - 04/2014
4AntiemeticsIBA
01/2021 - 01/2018
4Phosphotransferases (Kinase)IBA
01/2019 - 05/2006
4CytokinesIBA
07/2018 - 05/2006
4Immunoglobulin E (IgE)IBA
01/2017 - 04/2006
41,25-dihydroxyvitamin DIBA
12/2007 - 08/2003
3Indicators and Reagents (Reagents)IBA
04/2024 - 01/2021
3Tyrosine Kinase InhibitorsIBA
01/2024 - 03/2021
3EnzymesIBA
03/2023 - 11/2016
3AcidsIBA
01/2023 - 10/2015
3Amyloid beta-PeptidesIBA
01/2022 - 01/2008
3Opioid Analgesics (Opioids)IBA
01/2021 - 05/2017
3SphingosineIBA
12/2020 - 01/2018
3Alkaline PhosphataseIBA
06/2017 - 09/2014
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2016 - 09/2004
3Caspase 3 (Caspase-3)IBA
04/2016 - 09/2004
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2015 - 10/2005
3Superoxide Dismutase-1IBA
10/2015 - 07/2005
3ErythropoietinFDA Link
10/2014 - 09/2010
3SesquiterpenesIBA
03/2014 - 10/2002
3Levodopa (L Dopa)FDA LinkGeneric
11/2009 - 05/2008
3Interleukin-4 (Interleukin 4)IBA
05/2006 - 03/2006
2GalactosylceramidaseIBA
03/2024 - 11/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
02/2024 - 11/2016
2Imatinib Mesylate (Gleevec)FDA Link
02/2024 - 10/2022
2ProgranulinsIBA
02/2024 - 05/2014
2DNA-Binding Proteins (DNA Binding Protein)IBA
02/2024 - 03/2023
2RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2023 - 01/2022
2Uric Acid (Urate)IBA
02/2023 - 10/2015
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2023 - 12/2022

Therapy/Procedure

19Therapeutics
02/2024 - 10/2002
7Anesthesia
04/2024 - 01/2018
7Traditional Medicine (Folk Remedies)
11/2023 - 05/2017
4Length of Stay
04/2024 - 01/2020
4Radiotherapy
02/2024 - 01/2018
4General Anesthesia
01/2022 - 01/2018
4Neoadjuvant Therapy
06/2017 - 09/2014
3Craniotomy
04/2024 - 07/2020
3Oral Administration
01/2023 - 01/2009
3Precision Medicine
01/2020 - 01/2018
3Aftercare (After-Treatment)
04/2019 - 10/2012
2Gastrostomy
01/2024 - 01/2014
2Transplantation
01/2023 - 01/2010
2Immunotherapy
01/2023 - 01/2006